Compare ARK Genomic Revolution ETF (ARKG) vs AXT Inc (AXTI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs AXT Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while AXT Inc trades at $55.5 (market cap $3.74B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, AXT Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | AXTI | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $140.83 |
52-Week Low | $23.09 | $1.92 |
Market Cap | — | $3.74B |
Enterprise Value | — | $3.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
AXTI trades at $57.21, down 8.54% today amid bearish technical signals. The company shows negative profitability with a -14.68% net margin but has beaten EPS estimates in two of the last three quarters. Analyst consensus is bullish with 64% buy ratings, supported by a $100M backlog and AI-driven indium phosphide demand growth. Cash flow remains positive primarily from financing activities.
Near-term outlook hinges on Q2 2026 earnings due July 30, where analysts expect EPS of $0.07. Key opportunities include AI infrastructure expansion and capacity growth, while risks involve geopolitical tensions affecting Chinese exports and ongoing negative cash flow from operations. The stock faces resistance near $66 with support at $55.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →
